metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Tumor carcinoide ileal y colitis autolimitada
Información de la revista
Vol. 27. Núm. 6.
Páginas 362-364 (enero 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 27. Núm. 6.
Páginas 362-364 (enero 2004)
Acceso a texto completo
Tumor carcinoide ileal y colitis autolimitada
Carcinoid tumor of the ileum and self-limited colitis
Visitas
8677
D. Sánchez-Muñoz
Autor para correspondencia
dsanchezm@wanadoo.es

Correspondencia: Dr. D. Sánchez-Muñoz. Servicio de Aparato Digestivo. Hospital Universitario de Valme. Ctra. Cádiz, s/n. 41014 Sevilla. España.
, P. Guerrero Jiménez, M.V. Galán Jurado, E. Hoyas Pablos, M. Romero-Gómez, M. Castro-Fernández
Servicio de Aparato Digestivo. Hospital Universitario de Valme. Sevilla. España
Este artículo ha recibido
Información del artículo
Resumen

El tumor carcinoide ileal corresponde a la localización más frecuente de este tumor en el tracto gastrointestinal. Su asociación con la presencia de enfermedad inflamatoria intestinal está bien descrita. La colitis autolimitada es una entidad que plantea serias dificultades a la hora de realizar un diagnóstico diferencial con otras causas de colitis. Se presenta el caso de un paciente en el que se diagnosticó un tumor carcinoide ileal y en el que aparecieron datos clinicohistológicos de colitis autolimitada.

Carcinoid tumors of the ileum represent the most frequent localization of this type of tumor in the gastrointestinal tract. The association of this tumor with the presence of inflammatory bowel disease is well characterized. Self-limiting colitis is an entity that poses serious difficulties when performing a differential diagnosed by other causes of colitis. We present the case of a patient who was diagnosed with carcinoid tumor of the ileum. Clinical and histological findings of self-limiting colitis were also observed.

El Texto completo está disponible en PDF
Bibliografía
[1.]
J.B. Marshall, G. Bodnarchuk.
Carcinoid tumors of the gut.
J Clin Gastroenterol, 16 (1993), pp. 123-129
[2.]
A.P. Burke, R.M. Thomas, A.M. Elsayed, L.H. Sobin.
Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
Cancer, 79 (1997), pp. 1086-1093
[3.]
S. Saha, S. Hoda, R. Godfrey, C. Sutherland, K. Rabión.
Carcinoid tumors of the gastrointestinal tract: a 44-year experience.
South Med J, 82 (1989), pp. 1501-1505
[4.]
I.M. Modlin, K.D. Lye, M. Kidd.
A 5-decade analysis of 13,715 carcinoid tumors.
Cancer, 97 (2003), pp. 934-959
[5.]
I.M. Modlin, A. Sandor.
An analysis of 8305 carcinoid tumors.
Cancer, 79 (1997), pp. 813-829
[6.]
J. Ichikawa, S. Tanabe, W. Koizumi, Y. Kida, H. Imaizumi, M. Kida, et al.
Endoscopic mucosal resection in the management of gastric carcinoid tumors.
Endoscopy, 35 (2003), pp. 203-206
[7.]
S. Higaki, M. Nishiaki, N. Mitani, H. Yanai, M. Tada, K. Okita.
Effectiveness of local endoscopic resection of rectal carcinoid tumors.
Endoscopy, 29 (1997), pp. 171-175
[8.]
B.K. Mandal, P.F. Schofield, B.C. Morson.
A clinicopathological study of acute colitis: the dilemma of transient colitis syndrome.
Scand J Gastroenterol, 17 (1982), pp. 865-869
[9.]
C.M. Surawicz, R.C. Haggitt, M. Husseman, L.V. McFarland.
Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease.
Gastroenterology, 107 (1994), pp. 755-763
[10.]
J.L. Faucheron.
Toxicity of non-steroidal anti-inflammatory drugs in the large bowel.
Eur J Gastroenterol Hepatol, 11 (1999), pp. 389-392
[11.]
A. Madisch, F. Wiedbrauck, F. Marquard, M. Stolte, J. Hotz.
5-fluorouracil-induced colitis –a review based upon consideration of 6 cases.
Z Gastroenterol, 40 (2002), pp. 59-66
[12.]
V. Vila, E. Brullet, A. Montserrat, R. Bella, R. Campo, L. Colomer, et al.
Rectocolitis iatrógena por glutaraldehído.
Gastroenterol Hepatol, 24 (2001), pp. 409-410
[13.]
Y. Taha, M. Carlson, M. Thorn, L. Loof, Y. Raab.
Evidence of local eosinophil activation and altered mucosal permeability in collagenous colitis.
Dig Dis Sci, 46 (2001), pp. 888-897
[14.]
A.A. Abdo, S.J. Urbanski, P.L. Beck.
Lymphocytic and collagenous colitis: the emerging entity of microscopic colitis. An update on pathophysiology, diagnosis and management.
Can J Gastroenterol, 17 (2003), pp. 425-432
[15.]
S.A. Dundas, J. Dutton, P. Skipworth.
Reliability of rectal biopsy in distinguishing between chronic inflammatory bowel disease and acute self-limiting colitis.
Histopathology, 31 (1997), pp. 60-66
[16.]
G. Schumacher, B. Sandstedt, R. Mollby, B. Kollberg.
Clinical and histologic features differentiating non-relapsing colitis from first attacks of inflammatory bowel disease.
Scand J Gastroenterol, 26 (1991), pp. 151-161
[17.]
J.K. Greenson, R.A. Stem, S.L. Carpenter, J.L. Bamett.
The clinical significance of focal active colitis.
Hum Pathol, 28 (1997), pp. 729-733
[18.]
P. Tsang, H. Rotterdam.
Biopsy diagnosis of colitis: possibilities and pitfalls.
Am J Surg Pathol, 23 (1999), pp. 423-430
[19.]
C.M. Farr, W.P. Rajala.
Carcinoid tumor complicating ulcerative colitis.
Gastrointest Endosc, 36 (1990), pp. 315-316
[20.]
J. Kortbeek, J.K. Kelly, R.M. Preshaw.
Carcinoid tumors and inflammatory bowel disease.
J Surg Oncol, 49 (1992), pp. 122-126
[21.]
A.J. Greenstein, S. Balasubramanian, N. Harpaz, M. Rizwan, D.B. Sachar.
Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature.
Am J Gastroenterol, 92 (1997), pp. 682-685
[22.]
E. Nussinson, M. Samara, L. Vigder, I. Shafer, N. Tzur.
Concurrent collagenous colitis and multiple ileal carcinoids.
Dig Dis Sci, 33 (1998), pp. 1040-1044
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos